Vicarious Surgical (RBOT) Income towards Parent Company (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Income towards Parent Company came in at -$11.1 million in Q3 2025, up 35.3% year-on-year from -$8.2 million in Q3 2024, and up 16.32% on a QoQ basis from -$13.2 million in Q2 2025.
Vicarious Surgical (RBOT) Income towards Parent Company (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Income towards Parent Company data on file, last reported at -$11.1 million in Q3 2025.
- On a quarterly basis, Income towards Parent Company rose 35.3% year-over-year to -$11.1 million in Q3 2025; TTM through Dec 2025 was -$39.7 million, a 37.26% increase from a year earlier, with the FY2024 full-year figure at -$63.2 million, up 11.04% from the prior year.
- Income towards Parent Company for Q3 2025 stood at -$11.1 million, up from -$13.2 million in the prior quarter.
- Over the last five years, Income towards Parent Company for RBOT reached as high as $42.5 million in Q1 2022 and fell as low as -$45.1 million in Q3 2021.
- Historically, Income towards Parent Company has averaged -$10.7 million across 5 years, with a median of -$13.9 million in 2024.
- Across the five-year window, Income towards Parent Company slumped 24757.7% in 2021 and surged 912.98% in 2022, its largest moves.
- Year by year, Income towards Parent Company stood at $21.8 million in 2021, then slumped by 151.32% to -$11.2 million in 2022, then declined by 17.27% to -$13.1 million in 2023, then fell by 6.22% to -$13.9 million in 2024, then advanced by 20.59% to -$11.1 million in 2025.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$11.1 million in Q3 2025, -$13.2 million in Q2 2025, and -$15.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -11.06 Mn |
| Jun 30, 2025 | -13.22 Mn |
| Mar 31, 2025 | -15.39 Mn |
| Dec 31, 2024 | -13.93 Mn |
| Sep 30, 2024 | -17.09 Mn |
| Jun 30, 2024 | -15.21 Mn |
| Mar 31, 2024 | -17.00 Mn |
| Dec 31, 2023 | -13.11 Mn |
| Sep 30, 2023 | -15.70 Mn |
| Jun 30, 2023 | -15.33 Mn |
| Mar 31, 2023 | -26.92 Mn |
| Dec 31, 2022 | -11.18 Mn |
| Sep 30, 2022 | -24.74 Mn |
| Jun 30, 2022 | -1.45 Mn |
| Mar 31, 2022 | 42.53 Mn |
| Dec 31, 2021 | 21.79 Mn |
| Sep 30, 2021 | -45.12 Mn |
| Jun 30, 2021 | -6.64 Mn |
| Mar 31, 2021 | -5.23 Mn |
| Dec 31, 2020 | -3.78 Mn |